490 related articles for article (PubMed ID: 25368021)
1. Twist1 is a key regulator of cancer-associated fibroblasts.
Lee KW; Yeo SY; Sung CO; Kim SH
Cancer Res; 2015 Jan; 75(1):73-85. PubMed ID: 25368021
[TBL] [Abstract][Full Text] [Related]
2. Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.
Zhu X; Han S; Wu S; Bai Y; Zhang N; Wei L
Exp Cell Res; 2019 Feb; 375(2):41-50. PubMed ID: 30611739
[TBL] [Abstract][Full Text] [Related]
3. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
4. Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes.
Sung CO; Lee KW; Han S; Kim SH
Am J Pathol; 2011 Oct; 179(4):1827-38. PubMed ID: 21854747
[TBL] [Abstract][Full Text] [Related]
5. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression.
Butti R; Nimma R; Kundu G; Bulbule A; Kumar TVS; Gunasekaran VP; Tomar D; Kumar D; Mane A; Gill SS; Patil T; Weber GF; Kundu GC
Oncogene; 2021 Mar; 40(11):2002-2017. PubMed ID: 33603163
[TBL] [Abstract][Full Text] [Related]
7. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.
Yuan W; Li T; Mo X; Wang X; Liu B; Wang W; Su Y; Xu L; Han W
Oncotarget; 2016 May; 7(20):29507-19. PubMed ID: 27121055
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
10. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
11. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence.
Ansieau S; Bastid J; Doreau A; Morel AP; Bouchet BP; Thomas C; Fauvet F; Puisieux I; Doglioni C; Piccinin S; Maestro R; Voeltzel T; Selmi A; Valsesia-Wittmann S; Caron de Fromentel C; Puisieux A
Cancer Cell; 2008 Jul; 14(1):79-89. PubMed ID: 18598946
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
[TBL] [Abstract][Full Text] [Related]
13. HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
Li W; Wang Z; Zha L; Kong D; Liao G; Li H
Oncol Rep; 2017 Jan; 37(1):185-192. PubMed ID: 27878307
[TBL] [Abstract][Full Text] [Related]
14. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
15. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
[TBL] [Abstract][Full Text] [Related]
16. HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis.
Ding X; Ji J; Jiang J; Cai Q; Wang C; Shi M; Yu Y; Zhu Z; Zhang J
Cell Death Dis; 2018 Aug; 9(9):867. PubMed ID: 30158543
[TBL] [Abstract][Full Text] [Related]
17. Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis.
Palumbo-Zerr K; Soare A; Zerr P; Liebl A; Mancuso R; Tomcik M; Sumova B; Dees C; Chen CW; Wohlfahrt T; Mallano T; Distler A; Ramming A; Gelse K; Mihai C; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2017 Jan; 76(1):244-251. PubMed ID: 27113414
[TBL] [Abstract][Full Text] [Related]
18. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
19. Activation of TGF-β1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression.
Yang X; Hu J; Shi C; Dai J
Cancer Biother Radiopharm; 2020 Mar; 35(2):120-128. PubMed ID: 31742430
[No Abstract] [Full Text] [Related]
20. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
